|
|
|
|
|
|
PORTFOLIO PRIORITIZATION
Facing multiple possible lead indications, we helped our client define a logical
development path to minimize risk and optimize value.
PRICING AND REIMBURSEMENT STRATEGY
Pricing considerations influence almost every decision. Prior to launching a novel
oncology drug for the first of four indications, our client required a clear strategy
to optimize the initial launch price.
DIAGNOSTICS INDUSTRY STRATEGY
When the senior management team of a Fortune 500 diagnostics company needed an
advisor to challenge their thinking and develop an acquisition strategy, they
sought out Health Advances.
|
|
 |
|
|
|
|
